Sorry, you need to enable JavaScript to visit this website.

Engineering stable cytoplasmic intrabodies with designed specificity

TitoloEngineering stable cytoplasmic intrabodies with designed specificity
Tipo di pubblicazioneArticolo su Rivista peer-reviewed
Anno di Pubblicazione2003
AutoriDonini, Marcello, Morea V., Desiderio Angiola, Pashkoulov D., Villani Maria Elena, Tramontano A., and Benvenuto Eugenio
RivistaJournal of Molecular Biology
Volume330
Paginazione323-332
ISSN00222836
Parole chiaveantigen, antigen binding, article, binding affinity, Bioengineering, chimeric antibody, controlled study, cytoplasm, Escherichia coli, Eukaryota, lysozyme, molecule, nonhuman, oxidation, priority journal, Prokaryota, protein binding, protein expression, Recombinant antibody, Solubility
Abstract

Many attempts have been made to develop antibody fragments that can be expressed in the cytoplasm ("intrabodies") in a stable and functional form. The recombinant antibody fragment scFv(F8) is characterised by peculiarly high in vitro stability and functional folding in both prokaryotic and eukaryotic cytoplasm. To dissect the relative contribution of different scFv(F8) regions to cytoplasmic stability and specificity we designed and constructed five chimeric molecules (scFv-P1 to P5) in which several groups of residues important for antigen binding in the poorly stable anti-hen egg lysozyme (HEL) scFv(D1.3) were progressively grafted onto the scFv(F8) scaffold. All five chimeric scFvs were expressed in a soluble form in the periplasm and cytoplasm of Escherichia coli. All the periplasmic oxidised forms and the scFv(P3) extracted from the cytoplasm in reducing conditions had HEL binding affinities essentially identical (Kd=15nM) to that of the cognate scFv(D1.3) fragment (Kd=16nM). The successful grafting of the antigen binding properties of D1.3 onto the scFv(F8) opens the road to the exploitation of this molecule as a scaffold for the reshaping of intrabodies with desired specificities to be targeted to the cytoplasm. © 2003 Elsevier Science Ltd. All rights reserved.

Note

cited By 33

URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0037785117&doi=10.1016%2fS0022-2836%2803%2900530-8&partnerID=40&md5=7723eeed4d74d5b333caf78da7fa841f
DOI10.1016/S0022-2836(03)00530-8
Citation KeyDonini2003323